Park Ha Biological Technology Co., Ltd.

Listed Company

BYAHCIK 0001986247NasdaqNon-AcceleratedEmerging GrowthSoap, Detergents, Cleang Preparations, Perfumes, CosmeticsF4CNFY ends Oct 31

Period

FY 2025

Revenue

$2.52M

Net Income

$-24.36M

Total Assets

$5.95M

Equity

$3.99M

Shares Out

29.37M

Op. Cash Flow

$85.9K

Business

Park Ha Biological Technology Co., Ltd. develops and markets a private skincare brand, Park Ha, focusing on solutions for problematic and sensitive skin. It offers a broad line of ordinary cosmetic skincare products, signature serums and freeze-dried powders, complimentary in‑store “light beauty experience” services and training. Its operations are organized across business units—Park Ha Jiangsu for R&D and product development, Xinzhan for marketing and franchising, and Park Ha Shanghai for staff training and support. The company sells through directly operated stores, a nationwide franchise network across Chinese provinces and digital channels including social media, live streaming and O2O e-commerce platforms.

Summary from filing dated 2025-02-24

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	Oct 31, 2025 2025-10-31	Oct 31, 2024 2024-10-31	Oct 31, 2023 2023-10-31
Revenues, net	3	2	2
Cost of revenues	142,526	195,336	310,989
Gross profit	2	2	2
Operating expenses	—	—	—
Selling and marketing expenses	625,289	361,327	299,615
General and administrative expenses	25	814,857	484,955
Research and development expenses	238,184	36,714	30,881
Allowance for expected credit losses	184,204	179,903	152,108
Total operating expenses	27	1	967,559
Operating (loss) income	−24	793,714	1
Other income (expense):	—	—	—
Other income (expense)	58,738	−1,076	−575
Interest income	6,097	783	1,590
Interest expense	41	—	—
Total other income (expenses)	64,794	−293	1,015
(Loss) income before income tax	−24	793,421	1
Income tax expenses (benefits)	280,646	314,860	329,527
Net (loss) income	−24	478,561	852,042
Other comprehensive income (loss):	—	—	—
Foreign currency translation adjustments	−7,024	14,551	−28,111
Total comprehensive (loss) income	−24	493,112	823,931
(Loss) earnings per share:	—	—	—
Ordinary shares – basic (in Dollars per share)	−41.38	0.96	1.7
Ordinary shares – diluted (in Dollars per share)	−41.38	0.96	1.7
Weighted average shares outstanding used in calculating basic and diluted earnings per share:	—	—	—
Ordinary shares – basic (in Shares)	588,866	500,000	500,000
Ordinary shares – diluted (in Shares)	588,866	500,000	500,000

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	Oct 31, 2025 2025-10-31	Oct 31, 2024 2024-10-31
Current assets	—	—
Cash and cash equivalents	4	547,498
Accounts receivables, net	255,844	330,892
Due from related parties	2,062	14,339
Inventories, net	75,214	71,486
Advances to suppliers	9,384	19,168
Loans receivable from franchisees, net	1	745,992
Other receivables and other current assets	352,626	1
Total current assets	6	3
Non-current Assets	—	—
Property and equipment, net	157,999	103,960
Intangible assets, net	6,639	7,621
Operating lease right of use asset, net	180,243	70,739
Other non-current assets	105,773	56,717
Total non-current assets	450,654	239,037
TOTAL ASSETS	6	3
Current liabilities	—	—
Accounts payable	12,013	24,069
Due to related parties	7,026	—
Taxes payable	1	1
Operating lease liabilities – current	104,254	17,573
Contract liability	194,753	325,924
Accruals and other payables	188,312	155,863
Total current liabilities	2	2
Non-current liabilities	—	—
Operating lease liabilities – non-current	75,915	52,745
Total non-current assets	75,915	52,745
TOTAL LIABILITIES	2	2
Commitments and contingencies	—	—
Shareholders’ equity	—	—
Common Stock Value	677	500
Subscription receivable	—	—
Additional paid in capital	28	1
Statutory reserve	217,264	131,962
(Accumulated deficits) Retained earning	−24	271,788
Accumulated other comprehensive loss	−66,400	−59,376
Total Shareholders’ equity	4	2
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	6	3

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	Oct 31, 2025 2025-10-31	Oct 31, 2024 2024-10-31	Oct 31, 2023 2023-10-31
Cash flows from operating activities	—	—	—
Net (loss) income	−24	478,561	852,042
Depreciation and amortization	109,369	22,686	20,063
Allowance for credit losses	184,204	179,903	152,108
Allowance for Inventory	12,360	—	—
Inventory write-off	1,430	15,955	1,231
Deferred tax benefits	−26,671	−21,465	−33,737
Non-cash lease expenses	37,386	30,425	45,896
Share-based Compensation Expense	24	—	—
Other non-cash operating expense	−153,802	—	—
Changes in operating assets and liabilities:	—	—	—
Accounts receivable	−71,978	98,740	337,745
Inventories	17,458	−10,472	2,823
Advances to suppliers	−9,653	−76,909	−8,959
Other receivables and other current assets	324,318	36,862	265,755
Operating advance payments to related parties	35	—	—
Other non-current assets	20,323	−9,620	−178,016
Accruals and other payables	−1,843	27,450	35,281
Accounts payable	−11,894	−176,130	69,427
Taxes payable	369,232	403,396	437,310
Contract liability	−129,424	68,725	−989,082
Operating lease liabilities	−37,043	−30,435	−44,654
Net cash provided by operating activities	85,852	960,470	126,537
Cash flows from investing activities	—	—	—
Purchase of equipment and intangible assets	88,825	85,569	22,676
Loans to franchisees	1	1	311,083
Loan repayment from franchisees	604,964	810,660	1
Loans to the third party	6	—	—
Loans repayment from the third party	6	—	—
Advance to related parties	—	28,256	20,028
Repayment from related parties	14,145	31,540	15,597
Net cash (used in) provided by investing activities	−572,927	−508,143	1
Cash flows from financing activities	—	—	—
Proceeds from shareholder’s contribution of capital	—	500	38,265
Proceeds from issuance of shares	4	—	—
Borrowing from related parties	6,930	4,175	60,893
Repayment to related parties	—	73,310	776,083
IPO Cost	549,060	888,754	—
Net cash provided by (used in) financing activities	4	−957,389	−676,925
Net increase (decrease) in cash	3	−505,062	473,031
Effect of exchange rate changes on cash	−8,422	18,926	−14,108
Cash and cash equivalents– at the end of the year	—	—	—
Cash and cash equivalents– at the end of the year	—	—	—
Supplementary cash flow information:	—	—	—
Interest paid	—	—	—
Non-cash investing and financing activities:	—	—	—
Noncash obtained leasehold improvements	72,862	—	—
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	144,863	65,884	52,731

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro